Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Coloplast A/S    COLO B   DK0060448595

COLOPLAST A/S (COLO B)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 11/24 04:59:49 pm
499.2 DKK   -0.95%
11/16 COLOPLAST A/S : Insider tradings
11/06 COLOPLAST A/S : Insider tradings
11/02 Earnings drag on European shares, Credit Suisse shines
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Coloplast A/S : Patent Issued for Tool Useful for Implanting a Support in Treating Urinary Incontinence in a Patient (USPTO 9814456)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/21/2017 | 09:30pm CET

By a News Reporter-Staff News Editor at Health & Medicine Week -- Coloplast A/S (Humlebaek, DK) has been issued patent number 9814456, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors (see also Coloplast A/S).

The patent's inventors are Deitch, Sarah J. (Minneapolis, MN); Crabb, Rachael Anne Bergstrom (St. Paul, MN); Moschel, Mark A. (Plymouth, MN); Witzmann, Michael M. (Shoreview, MN).

This patent was filed on December 15, 2015 and was published online on November 14, 2017.

From the background information supplied by the inventors, news correspondents obtained the following quote: "Intracorporeal suturing of tissue during surgery presents challenges to the surgeon in that the surgeon is called upon to manipulate suturing instruments within the confines of a relatively small incision formed in the patient's body. In some cases, the surgeon is unable to see the suture site. In such a case, the surgeon will digitally palpate with a finger to locate a landmark within the intracorporeal site, and then deliver the suture near at or near the landmark. Tying of the suture inside the patient at the intracorporeal site can be challenging since the surgeon is unable to see the site.

"Improved suturing instruments and improved methods of delivering sutures would be welcomed by the surgical staff."

Supplementing the background information on this patent, NewsRx reporters also obtained the inventors' summary information for this patent: "One aspect provides an incontinence treatment system for a male patient. The system includes a support, a brace attachable to the support, and an introducer provided to deliver an anchor through the support and into periosteum tissue over a pubic bone of the pelvis of the male patient. The support has a body, a pair of lateral arms extending laterally from the body and a pair of longitudinal arms extending longitudinally from the body substantially orthogonal to the lateral arms. A pocket is formed at an end portion of each of the longitudinal arms. The brace includes a base portion, a first post extending from the base portion and a second post extending from the base portion. A first hanger is attached to an end portion of the first post and a second hanger is attached to an end portion of the second post. A first slot is formed between the end portion of the first post and the first hanger and a second slot is formed between the end portion of the second post and the second hanger. Each of the first and second hangers is sized to be inserted into the pocket that is formed at the end portion of each of the longitudinal arms. The anchor has a body, a spine projecting radially away from the body, an eyelet attached to a trailing end of the body, and a suture attached to the eyelet. The introducer has a cannula with a lumen that is sized to receive the body of the anchor and a slot formed through a wall of the cannula that is sized to receive the spine of the anchor. The spine of the anchor is configured to be fixated under the periosteum tissue and the suture is configured to secure the support in contact with the periosteum tissue."

For the URL and additional information on this patent, see: Deitch, Sarah J.; Crabb, Rachael Anne Bergstrom; Moschel, Mark A.; Witzmann, Michael M.. Tool Useful for Implanting a Support in Treating Urinary Incontinence in a Patient. U.S. Patent Number 9814456, filed December 15, 2015, and published online on November 14, 2017. Patent URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9814456.PN.&OS=PN/9814456RS=PN/9814456

Keywords for this news article include: Coloplast A/S, Urinary Incontinence, Urologic Diseases and Conditions.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

(c) 2017 NewsRx LLC, source Health Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on COLOPLAST A/S
11/21 COLOPLAST A/S : Patent Issued for Tool Useful for Implanting a Support in Treati..
11/16 COLOPLAST A/S : Insider tradings
11/06 COLOPLAST A/S : Insider tradings
11/02 COLOPLAST A/S : Patent Issued for Peyronie'S Treatment Implant (USPTO 9795483)
11/02 COLOPLAST A/S : Patent Issued for Pump for an Implantable Penile Prosthetic, the..
11/02 Earnings drag on European shares, Credit Suisse shines
11/02 COLOPLAST A/S : Announcement no. 7/2017 - Full-year Financial Results 2016/17
11/02 COLOPLAST A/S : delivers satisfactory full-year results and increases long-term ..
09/21 COLOPLAST A/S : Patent Issued for Method of Placing Suture through Tissue with a..
09/14 COLOPLAST A/S : Patent Issued for Method of Providing a Patient with an Implante..
More news
News from SeekingAlpha
11/05 Coloplast AS ADR 2017 Q4 - Results - Earnings Call Slides
11/04 Coloplast's (CLPBF) CEO Lars Rasmussen on Q4 2017 Results - Earnings Call Tra..
11/02 Coloplast ASB reports Q4 results
08/21 Coloplast (CLPBY) Investor Presentations - Slideshow
08/17 Coloplast's (CLPBF) CEO Lars Rasmussen on Q3 2017 Results - Earnings Call Tra..
Financials ( DKK)
Sales 2018 16 555 M
EBIT 2018 5 255 M
Net income 2018 4 030 M
Debt 2018 1 281 M
Yield 2018 3,00%
P/E ratio 2018 26,41
P/E ratio 2019 24,27
EV / Sales 2018 6,11x
EV / Sales 2019 5,66x
Capitalization 99 792 M
Chart COLOPLAST A/S
Duration : Period :
Coloplast A/S Technical Analysis Chart | COLO B | DK0060448595 | 4-Traders
Technical analysis trends COLOPLAST A/S
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 509  DKK
Spread / Average Target 0,91%
EPS Revisions
Managers
NameTitle
Lars Søren Rasmussen President & Chief Executive Officer
Michael Pram Rasmussen Chairman
Allan Rasmussen Executive Vice President-Global Operations
Anders Lonning-Skovgaard Chief Financial Officer & Executive Vice President
Oliver Johansen Senior VP-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
COLOPLAST A/S5.82%15 886
HENRY SCHEIN-7.78%10 979
CANTEL MEDICAL CORP.33.37%4 383
AMPLIFON SPA41.66%3 437
PATTERSON COMPANIES, INC.-13.99%3 377
MERIT MEDICAL SYSTEMS, INC.65.28%2 199